Committed to providing exceptional care and continued support to patients, families and caregivers.

Menu

NCT02111577

Disease Type: Genitourinary
Status: Open

Trial Information

A Randomized, Double-Blind, Multicenter, Parallel -Group, Phase III Study to Evaluate Efficacy and Safety of DCVAC /Pca Versus Placebo in Men with Metastatic Castration-Resistant Prostate Cancer Eligible for First Line Chemotherapy

Click here for more information

This trial is available at:

Midwest Cancer Center – Legacy
17201 Wright Street, Suite 200, Omaha, NE 68130
Phone: 402-334-4773
Fax: 402-330-7463

For more information, please contact: